Kanser Sonrası Yaşamın Yönetimi

Yıl 2022, Cilt: 11 Sayı: 1, 363 - 370, 19.03.2022

Yasemin Güçlüel , Gülbeyaz Can

https://doi.org/10.37989/gumussagbil.905218

Öz

Yüzyılımızın en önemli sağlık sorunlarından biri kanserdir. Son yıllardaki erken teşhis ve tedavi uygulamalarındaki gelişmeler, kanserden sağkalım oranlarını arttırmıştır. Literatürde, 2040 yılında kanser sağkalım sayısının 26,1 milyon üzerinde olacağı bildirilmiştir. Sağkalım sayılarındaki artışla birlikte kanser sonrası dönem ve bu dönemdeki bakımın önemi giderek artacaktır. Bu nedenle kanser sonrası dönemin yönetimi ile ilgili önleme, izleme, müdahale ve koordinasyon adımları ile ilgili stratejiler belirlenmelidir. Kanser hastaları kendilerine uygulanan tedaviden sonra birçok olumsuz etki ve sorunla karşılaşabilmektedir. Hastalar bu sorunlarla uzun yıllar baş etmek zorunda kalmakta ve yaşam kaliteleri olumsuz etkilenmektedir. Kanser tedavisinden sonra birçok sorun gözlenmesine rağmen, bu dönemi ve yaşanan sorunları inceleyen çalışmaların sayısı ise kısıtlıdır. Kanserden sağkalım oranlarının artması ile hastalarda tedavi sonrası yaşanan geç dönem yan etkilerin izlenmesine de olanak sağlanmış olacaktır. Bireylerin yaşadığı psikolojik ve fiziksel sorunları inceleyen kapsamlı çalışmaları gerçekleştirmek oldukça önemlidir. Bu dönemin daha uzun, daha kaliteli geçirilmesi ve sağkalım oranlarında artışların sağlanabilmesi için kanser sonrası dönemi, kanser ve tedavisine bağlı yaşanan uzun ve geç dönem etkileri iyi anlayabilmek, kanser tarama ve kontrollerini düzenli takip etmek, ortaya çıkan sonuçları doğru değerlendirmek gerekir. Bu derlemenin amacı kanser sonrası yaşama dikkat çekmek ve bu konuda farkındalık yaratmaktır.

Anahtar Kelimeler

kanser, Hemşirelik, Sağkalım.

Management of Life After Cancer

Öz

Cancer is the most important health problem today. Advances in early diagnosis and treatment practices in recent years have increased cancer survival rates. In literature, it has been reported that the number of cancer survival in 2040 will be over 26.1 million. With the increase in survival numbers, the importance of post-cancer period and care in this period will gradually increase. For this reason, strategies related to prevention, monitoring, intervention and coordination steps regarding the management of the post-cancer period should be determined. Cancer patients may encounter many negative effects and problems after the treatment applied to them. Patients have to cope with these problems for many years and their quality of life is negatively affected. Although many problems are observed after cancer treatment, the number of studies examining this period and the problems experienced is limited. With the increase in survival rates from cancer, it will be possible to monitor late-term side effects experienced after treatment in patients. It is very important to carry out comprehensive studies examining the psychological and physical problems experienced by individuals. It is necessary to understand the post-cancer period, the long-term and late-term effects due to cancer and its treatment, to follow cancer screening and controls regularly, and to evaluate the results correctly in order to have a longer and better quality of this period and to ensure an increase in survival rates. The aim of this review is to draw attention to life after cancer and to raise awareness about it.

Anahtar Kelimeler

Cancer, Nursing, Survival.

Kaynakça

• 1. Globocan. (2020). “The International Agency for Research on Cancer”. https://www.uicc.org/news/globocan-2020-new-global-cancer-data (Erişim Tarihi:13.01.2021).
• 2. American Cancer Society. (2019). “Cancer Treatment & Survivorship Facts & Figures 2019-2021”. American Cancer Society (1-45). Atlanta.
• 3. Miller, K.D , Nogueira, L, Mariotto, A. B, Rowland, J. H, Yabroff, K. R, Alfano, C. M, Jemal, A, Kramer J. L, and Siegel, R. L. (2019). “Cancer Treatment and Survivorship Statistics”. A Cancer Journal for Clinicians, 69 (3), 363-385.
• 4. Powel, R. L, Konings, S, Rankin, R, Koczwara, B, Kemp, B, Mazariego, C, and Butow, P. (2019). “A Meta-Review of Qualitative Research on Adult Cancer Survivors: Current Strengths and Evidence Gaps”. Journal of Cancer Survivorship, 13, 852-889.
• 5. Ekenga, C. C, Kwon, E, Kim, B. and Park, S. (2020). “Long-Term Employment Outcomes Among Female Cancer Survivors”. International Journal of Environmental Research and Public Health, 17 (8), 2751.
• 6. Ferlay, J, Colombet, M, Soerjomataram, I, Mathers, C, Parkin, D.M, Piñeros, M, Znaor, A. and Bray, F. (2019). “Estimating the Global Cancer İncidence and Mortality in 2018: Globocan Sources and Methods”. International Journal of Cancer, 144 (8), 1941-1953.
• 7. Aydın, A. (2020). “Sağkalanların Gereksinimleri ve Yaşadıkları Sorunlar”. In: G. CAN (Ed.). Onkoloji Hemşireliği (1069-1074). İstanbul: Nobel Tıp Kitapevi.
• 8. Pollack, L. A, Greer, G. E, Rowland, J. H, Miller, A, Doneski, D, Coughlin, S. S, Stovall, E. and Ulman D. (2005). “Cancer Survivorship: A New Challenge in Comprehensive Cancer Control”. Cancer Causes and Control, 16 (1), 51-59.
• 9. Aziz, N. M. (2009). “Cancer Survivorship Research: State of Knowledge, Challenges and Opportunities”. Acta Oncologica, 46 (4), 417-432.
• 10. Troeschel, A. N, Leach, C. R, Shuval, K, Stein, K. D. and Patel, A. V. (2018). “Physical Activity in Cancer Survivors During “Re-Entry” Following Cancer Treatment”. Preventing Chronic Disease, 15, 417-432.
• 11. Rowland, J. H, Mollica, M. and Kent, E. E. (2019). “Survivorship”. In: J.E. Niederhuber, J. Armitage, J. Doroshow, M. Kastan, J. Tepper (Edits.). Abeloff's Clinical Oncology (732-741). New York: Elsevier.
• 12. Siegel, R. L, Miller, D. K. and Jemal, A. (2020). “Cancer Statistics”. CA: A Cancer Journal for Clinicians, 70, 7-30.
• 13. Dewa, C. S, Trojanowski, L, Tamminga, S.J, Ringash, J, McQuestion, M. and Hoch, J. S. (2018). “Work-Related Experiences of Head and Neck Cancer Survivors: an Exploratory and Descriptive Qualitative Study”. Disability and Rehabilitation, 40 (11), 1252-1258.
• 14. Kılıç, S. T. and Öz, F. (2019). “Family Caregivers’ Involvement in Caring With Cancer and Their Quality of Life”. Asian Pacifıc Journal of Cancer Prevention, 20 (6), 1735-1741. doi: 10.31557/APJCP.2019.20.6.1735.
• 15. Truant, T. L, Fitch, M. I, O’Leary, C. and Stewart, J. (2017). “Global Perspectives on Cancer Survivorship: From Lost in Transition to Leading İnto the Future”. Canadian Oncology Nursing Journal, 27 (3), 287-294.
• 16. Natıonal Cancer Institute. https://www.cancer.gov, (Erişim tarihi:12.1.2021).
• 17. Fitch, M. I, Nicoll, I. and Lockwood, G. (2020). “Cancer Survivor's Perspectives on the Major Challenge in the Transition to Survivorship”. Patient Education and Counseling, 103 (11), 2361-2367.
• 18. Jones, J. M, Fitch, M, Bongard, J, Maganti, M, Gupta, A, D’Agostino, N. and Korenblum, C. (2020). “The Needs and Experiences of Post-Treatment Adolescent and Young Adult Cancer Survivors”. Journal of Clinical Medicine, 9 (5), 1444, 3-15.
• 19. Mullan, F. (1985). “Seasons of Survival: Reflections of a Physician with Cancer”. The New England Journal of Medicine, 313 (4), 270-273.
• 20. Marzorati, C, Riva, S. and Pravettoni, G. (2017). “Who Is a Cancer Survivor?” A Systematic Review of Published Definitions, 32 (2), 228–237.
• 21. Feuerstein, M. (2007). “Defining Cancer Survivorship”. Journal of Cancer Survivorship, 1 (1), 5-7.
• 22. Bluethmann, S.M, Mariotto, A.B. and Rowland, J.H. (2016). “Anticipating The "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden Among Older Cancer Survivors in The United States”. Cancer Epidemiology Biomarkers Prevention, 25 (7), 1029-1036.
• 23. Allemani, C, Matsuda, T, Di Carlo, V, Harewood, R, Matz, M, Niksic, M, Bonaventure, A, Valkov, M, Jhonson C. J, Esteve, Ogunbiyi, O. J. and Concord Working Group (2018). “Global Surveillance of Trends in Cancer Survival, 2000–14 (Concord-3): Analysis of İndividual Records for 37 513 025 Patients Diagnosed with one of 18 Cancers From 322 Population-Based Registries in 71 Countries”. The Lancet, 391, 10125-1075.
• 24. Stein, K.D, Syrjala, K.L. and Andrykowski, M.A. (2008). “Physical and Psychological Long-Term and Late Effects of Cancer”. Cancer, 112 (11), 2577–2592.
• 25. Bag, B. (2013). “Kanser Hastalarında Uzun Dönemde Görülen Psikososyal Sorunlar”. Psikiyatride Güncel Yaklaşımlar, 5 (1), 109-126.
• 26. De Boer, A.G, Torp, S, Popa, A, Horsboel, T, Zadnik, V, Rottenberg, Y, Bardi, E, Bultmann, U. and Sharp, L. (2020). “Long-Term Work Retention After Treatment for Cancer: A Systematic Review and Meta-Analysis”. Journal of Cancer Survivorship, 14 (2), 135-150.
• 27. Menhert, A. (2011). “Employment and Work-Related İssues in Cancer Survivors”. Critical Reviews in Oncology/Hematology, 77 (2), 109-130.
• 28. Kline, R. M, Arora, N. K, Bradley, C. J, Brauer, E. R, Graves, D. L, Lunsford, N. B, McCabe, M. S, Nasso, S. F, Nekhlyudov, L, Rowland, J.H, Schear, R.M. and Patricia A.G. (2018). “Long-Term Survivorship Care After Cancer Treatment- Summary of a 2017 National Cancer Policy Forum Workshop”. Journal of The National Cancer Institute, 110 (12), 1300-1310.
• 29. Hewitt, M, Sheldon Greenfield, S. and Stovall, E. (Eds.). (2006). “From Cancer Patient to Cancer Survivor Lost in Transition”. Institute of Medicine and National Research Council (23-165). Washington: DC National Academies Press.
• 30. Mollica, M. A, Mayer, D. K, Oeffinger, K. C, Kim, Y, Buckenmaier, S. S. and Sivaram, S. (2020). “Follow-Up Care For Breast and Colorectal Cancer Across The Globe: Survey Findings From 27 Countries”. Journal of Global Oncology, 6, 1394-1411.
• 31. Taskila, T, De Boer, A. G. E. M, Van Dijk, F. J. H. and Verbeek, J. H. A. M. (2011). “Fatigue and İts Correlates in Cancer Patients Who had Returned to Work—A Cohort Study”. Psycho-Oncology, 20, 1236–1241.
• 32. Bjerkeset, E, Röhrl, K, Bredal, I. S. (2020). “Symptom Cluster of Pain, Fatigue, and Psychological Distress in Breast Cancer Survivors: Prevalence and Characteristics”. Breast Cancer Research Treatment, 180 (1), 63-71.
• 33. Akın, S. (2020). “Kanser Tedavisinin Geç Etkileri”. In: G. CAN (Ed.). Onkoloji Hemşireliği (1243-1257). İstanbul: Nobel Tıp Kitapevi.
• 34. Treanor, C. J. and Donnelly, M. (2014). “The Late Effects of Cancer and Cancer Treatment: a Rapid Review”. The Journal of Community Support Oncology, 12 (4)1, 37-48.
• 35. Halpern, M. T, Viswanathan, M, Evans, T. S, Birken, S. A, Basch, E. and Mayer, D.K. (2015). “Models of Cancer Survivorship Care: Overview and Summary of Current Evidence”. Journal of Oncology Practice, 11 (1), 12-27.
• 36. LaGrandeur, W, Armin, J, Howe, C. L. and Ekberyan, L. A. (2018). “Survivorship Care Plan Outcomes for Primary Care Physicians, Cancer Survivors, and Systems: a Scoping Review”. Journal of Cancer Survivorship, 12 (3), 334-347.
• 37. Mccabe, M. S, Bhatia, S, Oeffinger, K. C, Reaman, G. H, Tyne, C, Wollins, D. S. and Hudson M. M. (2013). “American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care”. Journal of Clinical Oncology, 31 (5), 631–640.
• 38. Miller, K. D, Pandey, M, Jain, R. and Mehta, R. (2015). “Cancer Survivorship and Models of Survivorship Care a Review”. American Journal of Clinical Oncology, 38 (6), 627-633.
• 39. Watson, L, Lambert, L, Chapman. K. and Fitch, M.I. (2020). “Improving the Outcomes for Cancer Survivors in Canada: An İnteractive Approach to Competency Development Using The Newly Released Cano/Acıo Survivorship Manual”. Canadian Oncology Nursing Journal, 30 (4), 321–326.
• 40. Güçlüel, Y. ve Can, G. (2020). “Onkoloji Hizmetlerinin Organizasyonu ve Hemşirelik Yönetimi”. Gevher Nesibe Tıp ve Sağlık Bilimleri Dergisi, 5 (9), 34-42.